Embla Medical hf (OCSE:EMBLA)
kr 34.9 -0.7 (-1.97%) Market Cap: 14.90 Bil Enterprise Value: 18.15 Bil PE Ratio: 31.53 PB Ratio: 2.82 GF Score: 71/100

Q4 2023 Ossur hf Earnings Call Transcript

Jan 30, 2024 / 08:00AM GMT
Release Date Price: kr29.65 (+4.40%)
Sveinn SÃ;lvason Ã;ssur hf.;President and CEO

¶-

Good morning, everyone. Thanks for joining our call this morning with me here today, Ãssur's Arna our CFO. I will start with a few highlights then a review of the quarter and the year, and then conclude with our guidance for 2024, a Q&A session with then follow-up.

This has been an eventful year, and I would like to start with a few milestones and key highlights. In March, we introduced our Growth'27 strategy, a five-year strategy, focusing on reaching more people in need of mobility solutions with the ultimate goal of achieving 7% to 10% average local currency growth over this period.

Also at the same time to increase transparency in our financial reporting. We implemented a new sales segmentation prosthetics, bracing and support and patient care. And I'm very pleased to report that we're off to a good start with strong growth across all our business segments in 2023. EBITDA grew in line with sales and was positively impacted by strong growth, positive product mix and the lower freight cost.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot